This IDC Perspective highlights the importance of diversity and equity in clinical trials, acknowledging the deep-rooted disparities in healthcare. It discusses strategies employed by pharmaceutical companies to address these challenges, emphasizes the role of evolving technology, considers regulatory policies, and provides guidance on implementing diversity strategies, emphasizing the need for a sustained and collaborative effort.